The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.
about
Population genetics of malaria resistance in humansResistance to malaria in humans: the impact of strong, recent selectionDengue virus pathogenesis: an integrated viewChallenges for malaria elimination in BrazilPrimaquine or tafenoquine for preventing malaria in people travelling to or living in endemic areasPrimaquine in vivax malaria: an update and review on management issuesReview of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop reportThe anaemia of Plasmodium vivax malariaPrimaquine radical cure of Plasmodium vivax: a critical review of the literatureGlucose-6-Phosphate Dehydrogenase: Update and Analysis of New Mutations around the WorldHigh-throughput screening for small-molecule inhibitors of plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonaseDiscovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reducesThe impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in PakistanInherited glutathione reductase deficiency and Plasmodium falciparum malaria--a case studyG6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based mapG6PD deficiency at Sumba in Eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing Vivax malariaHeterogeneity of G6PD deficiency prevalence in Mozambique: a school-based cross-sectional survey in three different regionsInhibition of Glucose-6-Phosphate Dehydrogenase Could Enhance 1,4-Benzoquinone-Induced Oxidative Damage in K562 CellsGlucose-6-phosphate dehydrogenase deficiency and risk of diabetes: a systematic review and meta-analysis.Dengue fever virus in Pakistan: effects of seasonal pattern and temperature change on distribution of vector and virus.Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels.Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility.Haemolytic anaemia after nitrofurantoin treatment in a pregnant woman with G6PD deficiencyGlucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with asymptomatic malaria in a rural community in Burkina FasoRecombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiencyPerformance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti.Molecular epidemiological characterization and health burden of thalassemia in Jiangxi Province, P. R. China.Screening for glucose-6-phosphate dehydrogenase deficiency in neonates: a comparison between cord and peripheral blood samples.Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspotsPerformance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screeningEpidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and eliminationMolecular characterization of glucose-6-phosphate dehydrogenase deficient variants in Baghdad city - IraqComparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency.Neonatal hyperbilirubinemia in infants with G6PD c.563C > T VariantDistinguishing between selective sweeps from standing variation and from a de novo mutation.The reality of using primaquine.Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1.Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus.Dengue virus type 2 (DENV2)-induced oxidative responses in monocytes from glucose-6-phosphate dehydrogenase (G6PD)-deficient and G6PD normal subjects.
P2860
Q21032506-1EFC32C8-58ED-42A9-8B0B-E93634DFF046Q21034052-9E02533B-D316-4015-8277-B6E9C9190015Q24645380-F4DDE10E-7155-4E92-836E-E09990219277Q26315456-6A037CD1-B498-4144-B5BC-32CFE220D0BDQ26471722-9D1031BF-76C0-48B3-82EA-91A8A3C4B5A8Q27003856-8AC398BC-9FCF-4A9F-ADE4-74373CF6BE6DQ27024922-142ADF54-006A-4405-9B08-C1EA0077C790Q27026970-ADC0C9BC-CA2D-4E61-845D-3A6C20918669Q27027939-185FD816-D000-4973-BC19-3337F9EC706FQ28074566-B33BEEA5-CDBF-4E0A-8E0A-151DB0E32B43Q28264283-87DA0F14-277D-4F28-AEE2-D6D960FBA74BQ28271436-BF4783D0-2740-471D-9287-887F14A00DF2Q28474079-C3BA84D6-FB8B-4DE0-9233-72220831C7A4Q28476271-3D8C5585-9BDD-4F22-BE7A-E643C3162C50Q28485156-1EB463BC-54F8-4309-A11F-2D59918BA5DEQ28543894-1BFA14B3-F5CF-4B8C-B1C5-C186CA0EEC8FQ28559557-24BD08FC-DDF1-4899-90FE-0831539A4672Q28830356-53E45CDF-EF3D-4B42-A79D-A3F9D6E98136Q30235950-8C50EA00-54DC-45FE-923C-60543A6C8366Q30245613-1310603C-FD93-470E-BFAF-09E7886AF754Q30445380-D96E6033-AA20-434D-B93E-1584DBE50D5CQ33507529-FB03EBB8-D57D-47D0-8AD8-89269D7A30D2Q33628578-25B69E8A-942E-499A-A49D-14BA6D6ADF92Q33682046-7C166FD2-A1AD-4E8B-9970-491B78FDB247Q33731882-158A659E-4B16-468E-A28B-DF6DD072E11FQ33841156-1AE21050-2E1F-4A40-B538-2E388106DC8BQ33855578-9651A305-12A5-493F-A57A-47D6F65D9299Q33891774-2401E1C5-FD59-4099-AF94-978A09BABFC8Q33953373-56675622-A366-42CB-A25E-12FC684FEE63Q34075255-8F55757E-CB81-403C-8CBC-7F3943753F2BQ34099217-EAA59CE4-824E-400D-AB33-382A2CC24847Q34177472-0B02458D-D3DE-4F19-965F-B5CFE2442541Q34209338-BFFB0E38-84C2-47F1-BA9C-36B4028EB27AQ34281695-75517B75-9A5C-48CC-881F-54926A5ECCE8Q34385595-AB669F92-6E28-4D3E-8B4B-394B6786879EQ34446688-7554EEBB-1249-4498-B155-7A73F562F59BQ34478012-2A483D43-2F3D-4216-BCF2-1379FE70FB91Q34983798-E9B7E810-169E-4DF2-907B-E8E81DC95D29Q35041393-C4EF3B2D-2274-4E9E-8B36-2BA9ABEB228CQ35119732-DEF9E9FD-F921-4BE0-BF93-9CFFAC0654F0
P2860
The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The global prevalence of gluco ...... atic review and meta-analysis.
@en
The global prevalence of gluco ...... atic review and meta-analysis.
@nl
type
label
The global prevalence of gluco ...... atic review and meta-analysis.
@en
The global prevalence of gluco ...... atic review and meta-analysis.
@nl
prefLabel
The global prevalence of gluco ...... atic review and meta-analysis.
@en
The global prevalence of gluco ...... atic review and meta-analysis.
@nl
P2093
P921
P1476
The global prevalence of gluco ...... atic review and meta-analysis.
@en
P2093
Charles Poole
Ella T Nkhoma
Ernest Beutler
Susan A Hall
Vani Vannappagari
P304
P356
10.1016/J.BCMD.2008.12.005
P577
2009-02-23T00:00:00Z